Measurement, interpretation and clinical potential of QT dispersion

Journal of the American College of Cardiology

Volumn 36, Issue 6, 2000, Pages 1749-1766

  Malik, Marek ^a   Batchvarov, Velislav N ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL ERROR; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HEART REPOLARIZATION; HEART VENTRICLE CONTRACTION; HUMAN; MEASUREMENT; NORMAL VALUE; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; QT INTERVAL; RELIABILITY; REVIEW; T WAVE; WAVEFORM;

ANIMALS; ELECTROCARDIOGRAPHY; HEART CONDUCTION SYSTEM; HEART DISEASES; HEART RATE; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MYOCARDIAL INFARCTION; PROGNOSIS;

EID: 0034669268     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(00)00962-1     Document Type: Review

References (199)

1. Principal factor waveforms of the thoracic QRS complex
2. QT dispersion: An indication of arrhythmia risk in patients with long QT intervals
3. QT and dispersion of ventricular repolarization: The greatest fallacy in electrocardiography in the 1990s
4. Nonuniform recovery of excitability in ventricular muscle
5. Circus movement in rabbit atrial muscle as a mechanism of tachycardia. II: The role of nonuniform recovery, of excitability in the occurrence of unidirectional block, as studied with multiple microelectrodes
6. Characteristics and possible mechanism of ventricular arrhythmia dependent on the dispersion of action potential durations
7. Does QT dispersion reflect dispersion of ventricular recovery?
8. Electrocardiographic indexes of dispersion of ventricular repolarization: An isolated heart validation study
9. Comparison of ECG variables of dispersion of ventricular repolarization with direct myocardial repolarization measurements in the human heart
10. Dispersion of ventricular repolarization. Reality? Illusion? Significance?
11. Influence of lead selection and population on automated measurement of QT dispersion
12. Determinants of precordial QT dispersion in normal subjects
13. QT dispersion as an attribute of T-loop morphology
14. Mechanisms of the spatial distribution of QT intervals on the epicardial and body surfaces
15. QT dispersion does not represent electrocardiographic interlead hetero geneity of ventricular repolarization
16. T axis as an indicator of risk of cardiac events in elderly people
17. Analysis of twelve-lead t wave morphology for risk stratification after myocardial infarction
18. The measurement of the Q-T interval in acute heart disease
19. Influence of T wave amplitude on automatic QT measurement
20. Errors in manual measurement of QT intervals
21. Measurement error as a source of QT dispersion: A computerised analysis
22. Purkinje repolarization as a possible cause of the U wave in the electrocardiogram
23. Physiologic basis of the U wave
24. The role of M cells in acquired long QT syndrome, U waves and torsade de pointes
25. Cellular basis for the normal T wave and the electrocardiographic manifestations of the long-QT syndrome
26. Interobserver reproducibility of QT interval measurement and QT dispersion in patients after acute myocardial infarction
27. The measurement of the Q-T interval of the electrocardiogram
28. U wave: Facts, hypotheses, misconceptions, and misnomers
29. Reduction of QT-interval imprecision and variance by measuring the JT interval
30. Should the JT rather than the QT interval be used to detect prolongation of ventricular repolarization? An assessment in normal conduction and in ventricular conduction defects
31. Importance of lead selection in QT interval measurement
32. Spatial variation of QT intervals on normal persons and patients with acute myocardial infarction
33. Methodology of ORS interpretation in the Glasgow program
34. New algorithms for QT dispersion analysis
35. Methodology of the modular ECG analysis system MEANS
36. Hysteresis of the ventricular paced QT interval in response to abrupt changes in pacing rate
37. QTc dispersion predicts cardiac mortality in the elderly. The Rotterdam study
38. Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians. The Strong Heart Study
39. Rate correction of the QT interval
40. An improved method for adjusting the QT interval for heart rate (The Framingham Heart Study)
41. Temporal dispersion of recovery of excitability in atrium and ventricle as a function of heart rate
42. Programmed electrical stimulation for ventricular tachycardia induction in humans. I. The role of ventricular functional refractoriness in tachycardia induction
43. Dispersion of monophasic action potential duration: Demonstrable in humans after premature ventricular extrastimulation but not in steady state
44. Is QT dispersion heart rate dependent? What are the values of correction formulas for QT interval?
45. Is dispersion of ventricular repolarization rate dependent?
46. Mystery of QTc interval dispersion
47. Adjustment of QT dispersion assessed from 12 lead electrocardiograms for different number of analysed electrocardiographic leads: Comparison of stability of different methods
48. Coronary artery disease may alter the spatial dispersion of the QT interval at rest
49. Computerised measurements of QT dispersion in healthy subjects
50. Reduction of QT dispersion by sotalol following myocardial infarction
51. Three-lead measurement of QTc dispersion
52. Dispersion of repolarization evaluated in three orthogonal-type electrocardiographic leads: L1, aVF, V2
53. QT dispersion: Comparison of orthogonal, quasi-orthogonal, and 12-lead configurations
54. Influence of lead selection and population on automated measurement of QT dispersion
55. Short- and long-term reproducibility of QT, QTc, and QT dispersion measurement in healthy subjects
56. Dispersion of the QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction
57. QT dispersion in exercise-induced myocardial hypertrophy
58. QT Measurement: A comparison of three simple methods
59. Human precision of operating a digitizing board: Implications for electrocardiogram measurement
60. Computerised measurements of QT dispersion in healthy subjects
61. Comparison of automatic QT measurement techniques in the normal 12 lead electrocardiogram
62. Measuring QT dispersion: Man versus machine
63. Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion
64. Poor correlation of automated and manual QT dispersion measurements in patients and normal subjects
65. Accuracy of four automatic QT measurement techniques in cardiac patients and healthy subjects
66. QT interval and QT dispersion measured with the threshold method depend on threshold level
67. Dispersion of ventricular repolarization: A marker of ventricular arrhythmias in patients with previous myocardial infarction
68. Will QT dispersion play a role in clinical decision-making?
69. Utility of QT dispersion combined with the signal-averaged electrocardiogram in detecting patients susceptible to ventricular tachyarrhythmia
70. QT dispersion and its clinical utility
71. QT dispersion: Problems of methodology and clinical significance
72. Provocative tests in children with suspect congenital long QT syndrome
73. Dispersion of QT and QTc interval in healthy children, and effects of sinus arrhythmia on QT dispersion
74. Effects of age, sex, and race on ECG interval measurements
75. QT dispersion may be a useful adjunct for detection of myocardial infarction in the chest pain center
76. QT interval dispersion in chronic heart failure and left ventricular hypertrophy: Relation to autonomic nervous system and Holter tape abnormalities
77. Twelve-lead QT dispersion is smaller in women than in men
78. Gender-specific differences on QT dispersion measured in 1100 healthy subjects
79. QT dispersion should be adjusted for age: Observations from 1096 normal subjects
80. QT dispersion in healthy Chinese children and adolescents
81. Do we need age-adjustment of QT dispersion? Observations from 1096 normal subjects
82. QT dispersion - Lack of discriminating power
83. Dynamics of QT dispersion during myocardial infarction and ischemia
84. Effect of dipyridamole on QT dispersion in vasospastic angina pectoris
85. Acute ischemia: A dynamic influence on QT dispersion
86. QT dispersion and RR variations on 12-lead ECGs in patients with congestive heart failure secondary to idiopathic dilated cardiomyopathy
87. QT interval dispersion: A noninvasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias?
88. Dispersion of ventricular repolarization in dilated cardiomyopathy
89. QT dispersion in patients with chronic heart failure: Beta-blockers are associated with a reduction in QT dispersion
90. Athletic left ventricular hypertrophy is associated with increased QT dispersion: An observational study
91. The observation of the QT dispersion in left ventricular hypertrophy in weight lifters
92. QT dispersion in endurance athletes
93. QT interval dispersion in chronic heart failure and left ventricular hypertrophy: Relation to autonomic nervous system and Holter tape abnormalities
94. Relation of left ventricular mass and QT dispersion in patients with systemic hypertension
95. Dispersion of the QT interval and autonomic modulation of heart rate in hypertensive men with and without left ventricular hypertrophy
96. QT dispersion as a marker of left ventricular mass in essential hypertension
97. Left ventricular geometric patterns and QT dispersion in borderline and mild hypertension: Their evolution and regression
98. QT dispersion in hypertensive patients who had normal coronary angiogram with or without left ventricular hypertrophy
99. QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy
100. QT-interval abnormalities in hypertrophic cardiomyopathy
101. Dispersion of ventricular repolarization in hypertrophic cardiomyopathy
102. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome
103. Right ventricular monophasic action potentials in patients with long QT syndrome
104. Recording of monophasic action potentials of the right ventricle in long QT syndromes complicated by severe ventricular arrhythmias
105. Comprehensive assessment of QT dispersion in various at risk groups including acute myocardial infarction, unstable angina, hypertrophic cardiomyopathy, idiopathic dilated cardiomyopathy, and healthy controls
106. QT dispersion in patients with different aetiology of left ventricular hypertrophy
107. QT dispersion in exercise-induced myocardial hypertrophy
108. QT dispersion in athletic left ventricular hypertrophy
109. Left ventricular geometric patterns and QT dispersion in untreated essential hypertension
110. Dynamic changes of QT dispersion and its relationship with clinical variables and arrhythmic events after myocardial infarction
111. Effects of primary angioplasty on the course of QT dispersion after myocardial infarction and its association with infarct size
112. QT dispersion and early arrhythmic risk during acute myocardial infarction
113. Effects of post-myocardial infarction scar size, cardiac function, and severity of coronary artery disease on QT interval dispersion as a risk factor for complex ventriculararrhythmia
114. QT dispersion is determined by the extent of viable myocardium in patients with chronic Q-wave myocardial infarction
115. QT dispersion in essential hypertension
116. QT dispersion in dipper- and nondipper-type hypertension
117. Left ventricular geometric patterns and QT dispersion in untreated essential hypertension
118. QT dispersion and components of the QT interval in ischemia and infarction
119. Dynamic changes of QT dispersion and its relationship with clinical variables and arrhythmic events after myocardial infarction
120. Dynamics of QT dispersion during myocardial infarction and ischemia
121. Effect of balloon inflation-induced acute ischemia on QT dispersion during percutaneous transluminal coronary angioplasty
122. Electrophysiological effects of ischemic preconditioning on QT dispersion during coronary angioplasty
123. Effect of intracoronary balloon inflation at percutaneous transluminal coronary angioplasty on QT dispersion
124. Exercise-induced changes in the QT interval duration and dispersion in patients with sudden cardiac death after myocardial infarction
125. Acute ischemia: A dynamic influence on QT dispersion
126. Effects of ischemia and reperfusion on QT dispersion during coronary angioplasty
127. QT dispersion variability and myocardial viability in acute myocardial infarction
128. Does increased QT dispersion in the acute phase of anterior myocardial infarction predict recovery of left ventricular wall motion?
129. QT dispersion is determined by the extent of viable myocardium in patients with chronic Q-wave myocardial infarction
130. Reduction of QT interval dispersion by successful thrombolytic therapy in acute myocardial infarction. TEAM-2 study investigators
131. Multivariate assodates of QT dispersion in patients with acute myocardial infarction: Primacy of patency status of the infarct-related artery
132. Effect of coronary angioplasty on QT dispersion
133. Correlation of heart rate variability parameters and QT interval in patients after PTCA of infarct related coronary artery as an indicator of improved autonomic regulation
134. Change of QT dispersion after PTCA in angina patients
135. Effects of losartan and captopril on QT dispersion in elderly patients with heart failure
136. Left ventricular hypertrophy and QT dispersion in hypertension
137. Irbesartan reduces QT dispersion in hypertensive individuals
138. Regression of left ventricular hypertrophy results in improvement of QT dispersion in patients with hypertension
139. Reduction of QT and QTc dispersion during long-term treatment of systemic hypertension with enalapril
140. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome
141. Relationship between QT dispersion and the incidence of early ventricular arrhythmias in patients with acute myocardial infarction
142. QT dispersion as a noninvasive arrhythmogenic marker in acute myocardial infarction
143. Dispersion of ventricular repolarization and arrhythmic cardiac death in corornary artery disease
144. QT interval dispersion: A noninvasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias?
145. Prediction value of ventricular arrhythmia of patients with acute myocardial infarction by QT dispersion
146. Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction
147. Repolarization characteristics and sudden death after myocardial infarction: A case control study
148. Prognostic value of QT-interval and -dispersion in apparently healthy individuals. Resuits from the Munster heart study (PROCAM)
149. Precordial QT dispersion and inducible ventricular tachycardia
150. Antiarrhythmic drug effects on QT interval dispersion in patients undergoing electropharmacologic testing for ventricular tachycardia and fibrillation
151. A comparison of T-wave alternans and QT dispersion as noninvasive predictors of ventricular arrhythmias
152. QT-dispersion does not predict inducibility or adequate device treatment in patients with malignant ventricular tachyarrhythmias
153. T-Wave alternans and dispersion of the QT interval as risk stratification markers in patients susceptible to sustained ventricular arrhythmias
154. QT dispersion is not related to infarct size or inducibility in patients with coronary artery disease and life threatening ventricular arrhythmlas
155. Repolarization dispersion and sudden cardiac death in patients with impaired left ventricular function
156. QT interval dispersion as a predictor of arrhythmic events in congestive heart failure. Importance of aetiology
157. Dispersion of ORS and QT in patients with advanced congestive heart failure: Relation to cardiac and sudden cardiac death mortality
158. Effects of losartan and captopril on QT dispersion in elderly patients with heart failure
159. Randomised trial of losartan versus captopril in patients over 65 with heart failure
160. Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: Randomised trial - The Losartan Heart Failure Survival Study ELITE II
161. Prognostic implications of QT interval and dispersion in patients with congestive heart failure
162. The relationship between QT intervals and mortality in ambulant patients with chronic heart failure. The United Kingdom Heart Failure Evaluation and Assessment of Risk Trial (UK-HEART)
163. QT dispersion has no impact on mortality in patients with moderate and severe left ventricular dysfunction: Results from a cohort of 2263 patients
164. Prognostic value of arrhythmogenic markers in systemic hypertension
165. Comparison of QT dispersion in hypertrophic cardiomyopathy between patients with and without ventricular arrhythmias and sudden death
166. QT-interval variability in hypertrophic cardiomyopathy patients with cardiac arrest
167. Analysis of QT dispersion in patients with hypertrophic cardiomyopathy - Correlation with clinical data and survival (abstr)
168. QT dispersion and risk factors for sudden cardiac death in patients with hypertrophic cardiomyopathy
169. QT dispersion is not a predictor of sudden cardiac death in hypertrophic cardiomyopathy as assessed in an unselected patient population
170. Dispersion of the QT interval. A marker of therapeutic efficacy in the idiopathic long QT syndrome
171. Long QT: Good, bad, indifferent and fascinating
172. Drugs that prolong the QT interval: Regulatory and QT measurement issues from the United States and European perspectives
173. Precordial QT interval dispersion as a marker of Torsade de Pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone
174. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: Prospective comparison of sotalol versus quinidine
175. Reduction in QT dispersion by sotalol following myocardial infarction
176. Effects of amiodarone, sematilide, and sotalol on QT dispersion
177. Does sotalol-induced alteration of QT-dispersion predict drug effectiveness or proarrhythmic hazards?
178. Amiodazrone reduces QT dispersion in patients with hypertrophic cardiomyopathy
179. Influence of amiodarone on QT dispersion in patients with life-threatening ventricular arrhythmias and clinical outcome
180. Effect of amiodarone on QT dispersion in the 12-lead standard electrocardiogram and its significance for subsequent arrhythmic events
181. Amiodarone therapy after sotalol-induced torsade de pointes: Prolonged QT interval and QT dispersion in differentiation of pro-arrhythmic effects
182. Amiodarone induced torsades de pointes with excessive QT dispersion following quinidine induced polymorphic ventricular tachycardia
183. Amiodarone is associated with increased QT dispersion but low mortality in a CIDS cohort
184. Propafenone during acute myocardial ischemia in patients: A double-blind, randomized, placebo-controlled study
185. Factors influencing dispersion of repolarization under antiarrhythmic treatment
186. Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation of flutter: A prospective study
187. Effects of the class III antiarrhythmic drug dofetilide on ventricular monophasic action potential duration and the QT interval dispersion in stable angina pectoris
188. Effects of Azimilide, an IKs/IKr blocking anti arrhythmic on QT and QTc dispersion, in patients with ventricular tachycardia (VT)
189. Decreases by magnesium of QT dispersion and ventricular arrhythmias in patients with acute myocardial infarction
190. Effect of atenolol on QT Interval and dispersion in patients with Syndrome X
191. QT dispersion in patients with chronic heart failure: Beta-blockers are associated with a reduction in QT dispersion
192. Cellular and ionic basis for T-Wave alternans under long-QT conditions
193. The unidentified information content of the electrocardiogram
194. Principal factor waveforms of the thoracic ORS complex
195. Evaluation of the spatial aspects of T-wave complexity in the Iong-QT syndrome
196. T wave complexity in patients with hypertrophic cardiomyopathy
197. Mapping of ventricular repolarization potentials in patients with arrhythmogenic right ventricular dysplasia. Principal component analysis of the ST-T waves
198. T axis as an indicator of risk of cardiac events in elderly people
199. Spatial, temporal and wavefront direction characteristics of 12-Lead T wave morphology